Status:
COMPLETED
Early Pancreatic Duct Stent Removal in Preventing Post-endoscopic Pancreatitis
Lead Sponsor:
Nuovo Ospedale Civile S.Agostino Estense
Conditions:
Acute Pancreatitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Temporary pancreatic duct stent placement during endoscopic retrograde cholangiopancreatography (ERCP) has been recommended for post-endoscopic pancreatitis (PEP) prophylaxis in high risk patients, in...
Detailed Description
Recent meta-analyses of randomized controlled trials confirmed that pancreatic stent placement after ERCP reduces the risk of PEP but the optimal duration of stent placement remains an open question. ...
Eligibility Criteria
Inclusion
- All patients in whom accidental pancreatic duct cannulation had occurred
- during guide wire directed ERCP
Exclusion
- Patients who had undergone previous endoscopic papillectomy or sphincterotomy
- and those with an indwelled nasobiliary or nasopancreatic tube
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01449084
Start Date
December 1 2009
End Date
June 1 2011
Last Update
October 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nuovo Ospedale Civile S. Agostino-Estense
Modena, Italy, 41100